سعر ابيليفاي Abilify‏ 10مجم ديسكملت 10 اقراص ذائبة بالفم 2026

Aripiprazole 10 mg orodispersible tablets, atypical antipsychotic, pack of 10.

• Hypersensitivity to aripiprazole or to any of the excipients.International label, same formulation · European Medicines Agency (EPAR product information)

• Suicidality: close supervision of high-risk patients should accompany antipsychotic therapy.International label, same formulation · European Medicines Agency (EPAR product information)
• Neuroleptic malignant syndrome and tardive dyskinesia can occur; discontinue if signs develop as clinically appropriate.International label, same formulation · European Medicines Agency (EPAR product information)

• Strong CYP3A4 or CYP2D6 inhibitors (e.g. ketoconazole, quinidine, fluoxetine, paroxetine)Aripiprazole dose should be reduced to approximately one-half of its prescribed dose during co-administration.European Medicines Agency (EPAR product information)
• Strong CYP3A4 inducers (e.g. carbamazepine, rifampicin)Aripiprazole dose should be doubled during co-administration.European Medicines Agency (EPAR product information)

• Should not be used in pregnancy unless the expected benefit clearly justifies the potential risk to the fetus.International label, same formulation · European Medicines Agency (EPAR product information)
• Aripiprazole is excreted in human milk; decide whether to discontinue breastfeeding or therapy.International label, same formulation · European Medicines Agency (EPAR product information)

• Aripiprazole: Mechanism in schizophrenia and bipolar I disorder is not fully known; efficacy may be mediated by partial agonism at dopamine D2 and serotonin 5-HT1A receptors combined with antagonism at 5-HT2A receptors (US prescribing information).